Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Antibody Titers of RIG-C in Healthy Subjects
NCT02139657Phase 1Completed
- Sponsor
- Grifols
- Start
- Mar 2014
- Primary completion
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of rabies immune globulin (human) in rabies, sponsored by Grifols. Primary endpoint: Rabies Virus Antibody Titer at 10 days. Started Mar 2014; status: completed.
02
Drugs
rabies immune globulin (human)
03
Conditions
rabies
Beyond the preview
Go deeper on NCT02139657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02139657.